DR.AGAR.EYE | SCANDENT IMAGING | DR.AGAR.EYE/ SCANDENT IMAGING |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 46.3 | -1.1 | - | View Chart |
P/BV | x | 14.9 | 0.6 | 2,385.3% | View Chart |
Dividend Yield | % | 0.1 | 0.0 | - |
DR.AGAR.EYE SCANDENT IMAGING |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DR.AGAR.EYE Mar-24 |
SCANDENT IMAGING Mar-24 |
DR.AGAR.EYE/ SCANDENT IMAGING |
5-Yr Chart Click to enlarge
|
||
High | Rs | 3,550 | 15 | 24,002.7% | |
Low | Rs | 887 | 6 | 13,965.4% | |
Sales per share (Unadj.) | Rs | 679.4 | 7.4 | 9,171.5% | |
Earnings per share (Unadj.) | Rs | 98.6 | 2.3 | 4,245.7% | |
Cash flow per share (Unadj.) | Rs | 155.3 | 2.6 | 6,003.3% | |
Dividends per share (Unadj.) | Rs | 5.00 | 0 | - | |
Avg Dividend yield | % | 0.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 334.4 | 10.8 | 3,093.7% | |
Shares outstanding (eoy) | m | 4.70 | 54.01 | 8.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.3 | 1.4 | 228.8% | |
Avg P/E ratio | x | 22.5 | 4.6 | 494.3% | |
P/CF ratio (eoy) | x | 14.3 | 4.1 | 349.6% | |
Price / Book Value ratio | x | 6.6 | 1.0 | 678.3% | |
Dividend payout | % | 5.1 | 0 | - | |
Avg Mkt Cap | Rs m | 10,426 | 571 | 1,826.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 638 | 39 | 1,627.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,193 | 400 | 798.1% | |
Other income | Rs m | 52 | 32 | 162.5% | |
Total revenues | Rs m | 3,245 | 432 | 751.2% | |
Gross profit | Rs m | 920 | 68 | 1,355.4% | |
Depreciation | Rs m | 266 | 14 | 1,873.9% | |
Interest | Rs m | 83 | 4 | 1,971.5% | |
Profit before tax | Rs m | 623 | 81 | 765.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 159 | -44 | -359.8% | |
Profit after tax | Rs m | 464 | 125 | 369.5% | |
Gross profit margin | % | 28.8 | 17.0 | 169.8% | |
Effective tax rate | % | 25.5 | -54.3 | -47.0% | |
Net profit margin | % | 14.5 | 31.4 | 46.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 598 | 555 | 107.8% | |
Current liabilities | Rs m | 1,361 | 101 | 1,351.6% | |
Net working cap to sales | % | -23.9 | 113.5 | -21.0% | |
Current ratio | x | 0.4 | 5.5 | 8.0% | |
Inventory Days | Days | 78 | 77 | 101.0% | |
Debtors Days | Days | 1 | 3,104 | 0.0% | |
Net fixed assets | Rs m | 4,812 | 145 | 3,324.9% | |
Share capital | Rs m | 47 | 540 | 8.7% | |
"Free" reserves | Rs m | 1,525 | 44 | 3,498.2% | |
Net worth | Rs m | 1,572 | 584 | 269.2% | |
Long term debt | Rs m | 445 | 2 | 24,700.0% | |
Total assets | Rs m | 5,411 | 700 | 773.4% | |
Interest coverage | x | 8.5 | 20.3 | 41.8% | |
Debt to equity ratio | x | 0.3 | 0 | 9,174.8% | |
Sales to assets ratio | x | 0.6 | 0.6 | 103.2% | |
Return on assets | % | 10.1 | 18.5 | 54.5% | |
Return on equity | % | 29.5 | 21.5 | 137.2% | |
Return on capital | % | 35.0 | 14.6 | 239.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 16 | 0 | - | |
Fx outflow | Rs m | 12 | 0 | - | |
Net fx | Rs m | 5 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 898 | -4 | -23,938.7% | |
From Investments | Rs m | -700 | -4 | 17,082.9% | |
From Financial Activity | Rs m | -142 | -10 | 1,363.0% | |
Net Cashflow | Rs m | 55 | -18 | -300.7% |
Indian Promoters | % | 71.9 | 18.5 | 387.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.8 | 0.1 | 1,988.9% | |
FIIs | % | 0.8 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.1 | 81.5 | 34.5% | |
Shareholders | 4,510 | 45,369 | 9.9% | ||
Pledged promoter(s) holding | % | 55.5 | 61.7 | 89.9% |
Compare DR.AGAR.EYE With: APOLLO HOSPITALS NARAYANA HRUDAYALAYA DR. LAL PATHLABS KIMS METROPOLIS HEALTHCARE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | DR.AGAR.EYE | SCANDENT IMAGING |
---|---|---|
1-Day | -0.35% | -0.15% |
1-Month | -6.11% | -4.94% |
1-Year | 77.02% | -33.07% |
3-Year CAGR | 109.46% | -29.27% |
5-Year CAGR | 76.55% | -7.06% |
* Compound Annual Growth Rate
Here are more details on the DR.AGAR.EYE share price and the SCANDENT IMAGING share price.
Moving on to shareholding structures...
The promoters of DR.AGAR.EYE hold a 71.9% stake in the company. In case of SCANDENT IMAGING the stake stands at 18.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DR.AGAR.EYE and the shareholding pattern of SCANDENT IMAGING.
Finally, a word on dividends...
In the most recent financial year, DR.AGAR.EYE paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 5.1%.
SCANDENT IMAGING paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of DR.AGAR.EYE, and the dividend history of SCANDENT IMAGING.
Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.